Newsletter Archive

41. 02.25.26 -- STREAM Edition: CRL Transparency Comes With Real Trade-Secret Risks 2/25/2026

    02/25/26 Clinical Leader Newsletter

42. 02.24.26 -- When AI Meets Accounting: AI Costs And Intangible Asset Treatment For Sponsors And CROs 2/24/2026
    02/24/26 Clinical Leader Newsletter
43. 02.23.26 -- The U.S. Trial Advantage Is Eroding 2/23/2026
    02/23/26 Clinical Leader Newsletter
44. 02.21.26 -- The Case For Research-Naive PIs 2/21/2026
    02/21/26 Clinical Leader Newsletter
45. 02.20.26 -- Sponsors Collect Too Much "Non-Essential" Data, Say Tufts And TransCelerate 2/20/2026
    02/20/26 Clinical Leader Newsletter
46. 02.20.26 -- Partners To Elevate Your Clinical Trials 2/20/2026
    02/20/26 Clinical Leader Newsletter
47. 02.19.26 -- Could Moving To This Swiss Life Sciences Hub Be In Your Company's Future? 2/19/2026
    02/19/26 Clinical Leader Newsletter
48. 02.18.26 -- Making Medical Innovation Matter To Patients With Simplified Trial Design 2/18/2026
    02/18/26 Clinical Leader Newsletter
49. 02.18.26 -- STREAM Edition: Empower Efficient Clinical Study Execution 2/18/2026

    02/18/26 Clinical Leader Newsletter

50. 02.17.26 -- Digital Protocols Are At An Inflection Point 2/17/2026
    02/17/26